The Levothyrox affair does not run out of steam.

On Wednesday, October 4, 2017, the drug manufacturer Merck, announced in a statement that a stock of 60,000 additional boxes of Euthyrox, the old formula of Levothyrox, should be imported at the end of the week.

They are in addition to the 130,000 boxes already delivered and available in nearly 22,000 pharmacies since Monday, October 2. Patients who have already been able to get one have three months of treatment.

Problem: Patients denounce scandalous and deceptive delivery conditions.

Very limited stocks and special orders required

"I'm waiting for my box coming from Germany, I'm on the waiting list and I had to go back for a special order!" Marie-Noëlle V. protests on MC's Facebook page. "I'm going to my pharmacy there are only 1 boxes of each crazy day," says Zizou M. Even finding from Cat R.: "It's shameful, they put us on waiting list because they have only received a few boxes ... we are making fun of us. "

It seems that getting the drug Euthyrox is part of the obstacle course for patients who say they can no longer withstand such a situation and still persistent problems.

Very limited stocks, specific delivery (the prescription must be after September 14, 2017, specifically mention the name "Euthyrox" and only applies to people with serious side effects) ... In practice, everything is not so so simple and the situation remains unclear for many.

Perhaps the search, conducted Tuesday, October 3 at the headquarters of the German laboratory Merck based in Lyon as part of a preliminary investigation opened for "aggravated deception, involuntary injuries to the physical integrity and endangering the life of others " , will perhaps finally be able to shed light on this case?